Brain Natriuretic Peptide (BNP) Levels in Patients in Non Invasive Mechanical Ventilation
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00453726|
Recruitment Status : Completed
First Posted : March 29, 2007
Last Update Posted : October 5, 2009
|Condition or disease||Intervention/treatment||Phase|
|Respiratory Insufficiency||Procedure: Non invasive mechanical ventilation||Phase 4|
The aim of the study is to evaluate in patients with severe acute respiratory failure requiring non invasive mechanical ventilation BNP levels at admission and during the following 24 hours during non invasive mechanical ventilation (Non Invasive Positive Pressure Ventilation or Continuous positive airway pressure).
Because in patients affected by acute respiratory failure it is often difficult to distinguish if the disease precipitating the respiratory failure is a cardiac disease or a lung disease, aim of the present study is to evaluate the discriminating role that BNP could have in this group of patients; evaluation will be completed, once obtained clinical stabilisation, with an echocardiography and respiratory functional test.
|Study Type :||Observational|
|Estimated Enrollment :||40 participants|
|Official Title:||Evaluation of BNP in Patients With Severe Acute Respiratory Failure Requiring Non Invasive Mechanical Ventilation|
|Study Start Date :||May 2006|
|Study Completion Date :||July 2009|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00453726
|Ospedale San Giovanni Bosco Medicina d'Urgenza|
|Torino, Piedmont, Italy, 10154|
|Principal Investigator:||Giovanni Ferrari, MD||Ospedale San Giovanni Bosco ASL4 Torino Italy|